Skip to main content
Log in

EBV-based nasopharyngeal carcinoma screening cost effective in many populations worldwide

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Miller JA, et al. Cost-Effectiveness of Nasopharyngeal Carcinoma Screening with Epstein-Barr Virus Polymerase Chain Reaction or Serology in High-Incidence Populations Worldwide. Journal of the National Cancer Institute : 22 Dec 2020. Available from: URL: http://doi.org/10.1093/jnci/djaa198

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

EBV-based nasopharyngeal carcinoma screening cost effective in many populations worldwide. PharmacoEcon Outcomes News 869, 12 (2021). https://doi.org/10.1007/s40274-021-7379-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-021-7379-7

Navigation